LGMD2B
Clinical trial pipeline · Data from ClinicalTrials.gov
See which LGMD2B trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which LGMD2B trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary purpose of this study is to evaluate the safety of SRP-6004 administered by intravenous (IV) infusion in ambulatory participants with LGMD2B/R2 (DYS…
To evaluate specific characteristics of phenotype, immune status, molecular and genetic as well as morphological characteristics of adult patients with limb-gir…